HomeCompareCMXC vs PLD

CMXC vs PLD: Dividend Comparison 2026

CMXC yields 470.59% · PLD yields 3.18%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 CMXC wins by $38538.61M in total portfolio value
10 years
CMXC
CMXC
● Live price
470.59%
Share price
$0.43
Annual div
$2.00
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$38545.12M
Annual income
$27,182,357,871.92
Full CMXC calculator →
PLD
PLD
● Live price
3.18%
Share price
$128.78
Annual div
$4.10
5Y div CAGR
74.4%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$6.50M
Annual income
$5,256,436.18
Full PLD calculator →

Portfolio growth — CMXC vs PLD

📍 CMXC pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodCMXCPLD
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, CMXC + PLD cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
CMXC pays
PLD pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

CMXC
Annual income on $10K today (after 15% tax)
$40,000.00/yr
After 10yr DRIP, annual income (after tax)
$23,105,004,191.13/yr
PLD
Annual income on $10K today (after 15% tax)
$270.62/yr
After 10yr DRIP, annual income (after tax)
$4,467,970.75/yr
At 15% tax rate, CMXC beats the other by $23,100,536,220.38/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of CMXC + PLD for your $10,000?

CMXC: 50%PLD: 50%
100% PLD50/50100% CMXC
Portfolio after 10yr
$19275.81M
Annual income
$13,593,807,154.05/yr
Blended yield
70.52%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on PLD right now

CMXC
No analyst data
Altman Z
-276.8
Piotroski
3/9
PLD
Analyst Ratings
25
Buy
16
Hold
1
Sell
Consensus: Buy
Price Target
$136.00
+5.6% upside vs current
Range: $119.00 — $155.00
Altman Z
1.9
Piotroski
5/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

CMXC buys
0
PLD buys
0
No recent congressional trades found for CMXC or PLD in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricCMXCPLD
Forward yield470.59%3.18%
Annual dividend / share$2.00$4.10
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR0%74.4%
Portfolio after 10y$38545.12M$6.50M
Annual income after 10y$27,182,357,871.92$5,256,436.18
Total dividends collected$37542.88M$6.37M
Payment frequencyquarterlyquarterly
SectorStockREIT

Year-by-year: CMXC vs PLD ($10,000, DRIP)

YearCMXC PortfolioCMXC Income/yrPLD PortfolioPLD Income/yrGap
1← crossover$57,759$47,058.82$11,255$555.24+$46.5KCMXC
2$315,826$254,024.51$13,062$1,018.59+$302.8KCMXC
3$1,636,076$1,298,141.44$15,903$1,926.67+$1.62MCMXC
4$8,035,425$6,284,824.27$20,839$3,823.32+$8.01MCMXC
5$37,445,846$28,847,941.19$30,464$8,166.08+$37.42MCMXC
6$165,706,448$125,639,392.36$52,054$19,457.30+$165.65MCMXC
7$696,916,266$519,610,366.98$109,886$54,188.93+$696.81MCMXC
8$2,788,074,169$2,042,373,764.24$304,030$186,451.18+$2787.77MCMXC
9$10,619,401,952$7,636,162,591.12$1,166,125$840,813.32+$10618.24MCMXC
10$38,545,117,961$27,182,357,871.92$6,504,190$5,256,436.18+$38538.61MCMXC

CMXC vs PLD: Complete Analysis 2026

CMXCStock

Cell MedX Corp., a biotech company, focuses on the discovery, development, and commercialization of therapeutic and non-therapeutic products for patients with diabetes, Parkinson's disease, high blood pressure, neuropathy, and kidney functions. It develops and manufactures eBalance Pro System for professional use by healthcare practitioners in a clinical setting; and eBalance Home System for home use for general wellness and pain management treatment, which are controlled by the eBalance Console that acts as the central controller for three pre-programmed microcurrent algorithms, including wellness, pain management, and dual. The company was formerly known as Sports Asylum, Inc. and changed its name to Cell MedX Corp. in September 2014. Cell MedX Corp. was incorporated in 2010 and is based in Carson City, Nevada.

Full CMXC Calculator →

PLDREIT

Prologis, Inc. is the global leader in logistics real estate with a focus on high-barrier, high-growth markets. As of December 31, 2020, the company owned or had investments in, on a wholly owned basis or through co-investment ventures, properties and development projects expected to total approximately 984 million square feet (91 million square meters) in 19 countries. Prologis leases modern logistics facilities to a diverse base of approximately 5,500 customers principally across two major categories: business-to-business and retail/online fulfillment.

Full PLD Calculator →
📬

Get this CMXC vs PLD comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

CMXC vs SCHDCMXC vs JEPICMXC vs OCMXC vs KOCMXC vs MAIN

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.